« Return to News | Miscellaneous

Datatrak Q3 Sales Drop by a Third, Loss Narrows

Tuesday, November 17, 2009 07:30 AM

Datatrak International, a technology and services company focused on eClinical solutions, reported third quarter revenues fell 34% to $1.55 million compared with the prior year quarter but its net loss narrowed.

Compared to the prior year third quarter, combined direct cost and selling, general and administrative expenses decreased approximately $1.8 million, or nearly in half.

Datatrak reported a net loss of $(424,000), or $(0.03) per share on a basic and diluted basis, compared with a net loss of $(1.6 million), or $(0.12) per share on a basic and diluted basis, for the same time period of 2008.  Last year's third quarter net loss included a charge of $835,000 related to its German subsidiary office closing. In addition, the company's financial results for the prior year third quarter were negatively impacted by legal costs of $234,000 associated with litigation, which was favorably concluded in December 2008 resulting in the forgiveness of $3 million previously owed by Datatrak.

At Sept. 30, backlog was $8.89 million compared with $8.55 million at June 30. The Sept. 30 backlog amount represents the first quarter-over-quarter increase in backlog since the first quarter of 2008.

During the third quarter, the company’s cash balance declined $303,000 to $1.33 million at Sept. 30., compared with $1.63 million as of June 30.

"We believe the increase in backlog is a very good indicator that clinical trial sponsors are ready to move forward with projects which were on hold earlier this year,” said Laurence Birch, chairman of the board of Datatrak.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.